Spark Therapeutics Enters into Licensing Agreement with Genethon – GlobeNewswire (press release)
|
Spark Therapeutics Enters into Licensing Agreement with Genethon
GlobeNewswire (press release) PHILADELPHIA and EVRY, France, Sept. 20, 2017 (GLOBE NEWSWIRE) — Spark Therapeutics (NASDAQ:ONCE), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, today announced it has entered into a … |
